Sign in or create an account to add this stock to your watchlist.
About Motif Bio (LON:MTFB)
Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Motif Bio plc was incorporated in 2014 and is based in New York, New York.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
SymbolLON:MTFB
CUSIPN/A
PhoneN/A
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on Equity-773.10%
Return on Assets-183.64%
Miscellaneous
EmployeesN/A
Outstanding Shares263,130,000
Motif Bio (LON:MTFB) Frequently Asked Questions
What is Motif Bio's stock symbol?
Motif Bio trades on the London Stock Exchange (LON) under the ticker symbol "MTFB."
What price target have analysts set for MTFB?
5 equities research analysts have issued 1 year price targets for Motif Bio's stock. Their forecasts range from GBX 100 to GBX 115. On average, they anticipate Motif Bio's share price to reach GBX 109.20 in the next year. View Analyst Ratings for Motif Bio.
Who are some of Motif Bio's key competitors?
Some companies that are related to Motif Bio include BioTime (BTX), Resverlogix (RVX), 22nd Century Group (XXII), Protalix BioTherapeutics (PLX), Neptune Wellness Solutions (NEPT), Monash IVF Gr (MVF), Horizon Discovery (HZD), IMV (IMV), Bionomics (BNO), Fennec Pharmaceuticals (FRX), ImmunoVaccine (IMMVF), Arix Bioscience (ARIX), Mereo BioPharma Group (MPH), Ampio Pharmaceuticals (AMPE) and Immupharma (IMM).
Who are Motif Bio's key executives?
Motif Bio's management team includes the folowing people:
- Mr. Graham George Lumsden, CEO & Exec. Director (Age 58)
- Mr. Jonathan E. Gold, Interim CFO, Strategic Financial Consultant & Non-Exec. Director (Age 45)
- Mr. Robert Joseph Bertoldi, Exec. Director (Age 64)
- Dr. David B. Huang M.D., Ph.D., MBA, J.D., Chief Medical Officer (Age 43)
- Mr. Robert Dickey IV, Advisor (Age 62)
Has Motif Bio been receiving favorable news coverage?
Media headlines about MTFB stock have trended somewhat positive on Thursday, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Motif Bio earned a news impact score of 0.02 on Accern's scale. They also gave news coverage about the company an impact score of 46.83 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.
How do I buy shares of Motif Bio?
Shares of MTFB and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Motif Bio's stock price today?
One share of MTFB stock can currently be purchased for approximately GBX 32.
How big of a company is Motif Bio?
Motif Bio has a market capitalization of £93.75 million.
MarketBeat Community Rating for Motif Bio (MTFB)
MarketBeat's community ratings are surveys of what our community members think about Motif Bio and other stocks. Vote "Outperform" if you believe MTFB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTFB will underperform the S&P 500 over the long term. You may vote once every thirty days.
Motif Bio (LON:MTFB) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
5 Wall Street analysts have issued ratings and price targets for Motif Bio in the last 12 months. Their average twelve-month price target is GBX 109.20The high price target for MTFB is GBX 115 and the low price target for MTFB is GBX 100. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.80 | 2.80 | 2.75 | 2.80 |
| Ratings Breakdown: | 0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | GBX 109.20 | GBX 101.50 | GBX 102 | GBX 101.50 |
Motif Bio (LON:MTFB) Consensus Price Target History
Motif Bio (LON:MTFB) Analyst Ratings History
Show:
(Data available from 5/24/2016 forward)
Motif Bio (LON:MTFB) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Motif Bio (LON MTFB) Insider Trading and Institutional Ownership History
Motif Bio (LON MTFB) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 10/5/2015 | Stakes III,John Wilbur | Insider | Buy | 100,000 | GBX 60 | £60,000 | | |
(Data available from 1/1/2013 forward)
Motif Bio (LON MTFB) News Headlines
| Source: |
|
Motif Bio (LON:MTFB) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Motif Bio (LON MTFB) Stock Chart for Thursday, May, 24, 2018
Loading chart…
